Daniel Billen
Chairman at AURINIA PHARMACEUTICALS INC.
Net worth: 137 047 $ as of 2024-04-29
Daniel Billen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Independent Dir/Board Member | 2019-04-28 | - |
| Chairman | 2023-08-17 | - | |
| Director/Board Member | 2019-04-28 | 2023-08-17 |
Career history of Daniel Billen
Former positions of Daniel Billen
| Companies | Position | Start | End |
|---|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 2010-12-31 | 2017-12-31 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 1990-12-31 | 2010-12-31 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Sales & Marketing | 1978-12-31 | 1990-12-31 |
Training of Daniel Billen
| Université Catholique de Louvain | Doctorate Degree |
Statistics
International
| Canada | 4 |
| Belgium | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Daniel Billen
- Experience
